Correlation Between Allogene Therapeutics and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and Crispr Therapeutics AG, you can compare the effects of market volatilities on Allogene Therapeutics and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and Crispr Therapeutics.
Diversification Opportunities for Allogene Therapeutics and Crispr Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Allogene and Crispr is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Allogene Therapeutics and Crispr Therapeutics
Given the investment horizon of 90 days Allogene Therapeutics is expected to generate 1.9 times more return on investment than Crispr Therapeutics. However, Allogene Therapeutics is 1.9 times more volatile than Crispr Therapeutics AG. It trades about 0.01 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.02 per unit of risk. If you would invest 184.00 in Allogene Therapeutics on October 20, 2024 and sell it today you would lose (2.00) from holding Allogene Therapeutics or give up 1.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.0% |
| Values | Daily Returns |
Allogene Therapeutics vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Allogene Therapeutics |
| Crispr Therapeutics |
Allogene Therapeutics and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allogene Therapeutics and Crispr Therapeutics
The main advantage of trading using opposite Allogene Therapeutics and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |